3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1195

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

N/A

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

-0.01 (-1.79%)

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0177-OL:HK JIANGSU EXPRESS

-0.05 (-0.63%)

N/A
0240-OL:HK BUILD KING HOLD

-0.08 (-7.14%)

N/A
0243-OL:HK QPL INT'L

N/A

N/A
0182-OL:HK CHINA WINDPOWER

-0.01 (-1.64%)

N/A
0259-OL:HK YEEBO (INT'L H)

-0.03 (-0.81%)

N/A
0187-OL:HK JINGCHENG MAC

+0.06 (+2.69%)

N/A

ETFs Containing 3020-OL:HK

DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

N/A

CAD 0.02B
IHF iShares U.S. Healthcare P.. 9.59 % 0.43 %

-0.19 (0.46%)

USD 0.82B
TETF 6.19 % 0.64 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 5.11 % 0.75 %

N/A

CAD 0.08B
WBIL WBI BullBear Quality 3000.. 4.55 % 1.07 %

-0.01 (0.46%)

USD 0.04B
IAI iShares U.S. Broker-Deale.. 4.28 % 0.42 %

+0.86 (+0.46%)

USD 0.49B
PSL Invesco DWA Consumer Stap.. 3.89 % 0.60 %

+0.53 (+0.46%)

USD 0.09B
CBUF:XETRA iShares MSCI World Health.. 3.51 % 0.00 %

+0.05 (+0.46%)

USD 1.13B
HDIV 2.83 % 0.00 %

N/A

N/A
PVAL Putnam Focused Large Cap .. 2.73 % 0.29 %

+0.06 (+0.46%)

USD 0.31B
SPVU Invesco S&P 500® Enhance.. 2.73 % 0.16 %

-0.10 (0.46%)

USD 0.11B
UC96:LSE UBS (Irl) ETF plc - Facto.. 2.37 % 0.00 %

+24.50 (+0.46%)

USD 0.35B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 2.37 % 0.00 %

+11.25 (+0.46%)

USD 8.21M
UBUS:F UBS (Irl) ETF Public Limi.. 2.35 % 0.00 %

+0.22 (+0.46%)

USD 0.33B
UBUW:F UBS (Irl) ETF Public Limi.. 2.35 % 0.00 %

+0.08 (+0.46%)

USD 0.02B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 2.35 % 0.00 %

+0.36 (+0.46%)

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 2.35 % 0.00 %

+0.20 (+0.46%)

USD 0.05B
NSGE:CA NBI Sustainable Global Eq.. 2.32 % 0.00 %

+0.44 (+0.46%)

CAD 0.53B
XHS SPDR® S&P Health Care Se.. 2.13 % 0.35 %

+0.19 (+0.46%)

USD 0.08B
FXH First Trust Health Care A.. 2.13 % 0.63 %

+0.18 (+0.46%)

USD 1.33B
SPVM Invesco S&P 500 Value wit.. 1.78 % 0.39 %

-0.13 (0.46%)

USD 0.09B
RYH 1.72 % 0.40 %

N/A

N/A
HONR 1.20 % 0.65 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.64 % 0.40 %

+0.16 (+0.46%)

CAD 0.35B
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.01 (+0.46%)

USD 5.46M
DUSA 0.00 % 0.63 %

N/A

N/A
DRFU:CA Desjardins RI USA Multifa.. 0.00 % 0.57 %

N/A

CAD 5.97M
RYF 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

+1.46 (+0.46%)

USD 4.20B
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

+0.31 (+0.46%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.75% 81% B- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.75% 81% B- 81% B-
Trailing 12 Months  
Capital Gain 32.22% 92% A 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.22% 92% A 89% A-
Trailing 5 Years  
Capital Gain 98.50% 85% B 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 98.50% 85% B 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 13.89% 79% B- 79% B-
Dividend Return 13.89% 76% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.67% 71% C- 71% C-
Risk Adjusted Return 70.62% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike